I/O in Lung Cancer - 7: Oncologist Sees Promise in I/O-I/O Combos, Prods Quest for Cure

Yuichiro Ohe, MD, Deputy Director, Chief, Department of Thoracic Oncology, National Cancer Center Hospital Keytruda (pembrolizumab) obviously has a big edge in the immuno-oncology race for the treatment of lung cancer, but people should not downplay the benefit of the...read more